期刊文献+

混合性高甘油三酯/高胆固醇血症小鼠模型的培育 被引量:3

Development of Combined Hypercholesterolemic/Hypertriglyceridemic Mouse Model
下载PDF
导出
摘要 目的通过脂蛋白脂酶(lipoprotein lipase,LPL)基因敲除极度高甘油三酯血症小鼠LPLO与ApoE基因敲除高胆固醇血症小鼠ApoEO杂交,产生混合性高甘油三酯/高胆固醇血症小鼠模型LPLO/ApoEO。方法采用杂交、回交、互交的方法进行培育,并以重组腺病毒为载体在初生小鼠四肢肌肉内表达LPL基因有益突变体LPL447,救治出生2 d内即死亡LPLO/ApoEO纯合子初生小鼠。采用从LPLO/ApoEO小鼠的个体组织(鼠尾)中提取基因组DNA进行PCR分析和血浆脂质检测个体基因型。结果LPL基因有益突变体在纯合子小鼠体内短暂表达,能够成功救治LPLO/ApoEO双基因敲除小鼠。成年小鼠表现为极度的混合性高脂血症,其血浆甘油三酯和胆固醇水平分别是正常小鼠的76和14倍。结论成功培育了LPLO/ApoEO双基因敲除的遗传性混合性高甘油三酯、高胆固醇血症小鼠模型。 Objective To establish a combined hypercholesterolemic/hypertriglyceridemic mouse model by cross-breeding of LPL and ApoE knockout mice. Methods The model was developed by crossbred, backcross and intercross of the 2 lines of knockout mice, and rescued by muscular expression of a LPL beneficial mutant in homozygous neonates. The genotype was determined by PCR and confirmed by blood lipid assay. Results The LPL and ApoE double knockout mice could be rescued by muscular expression of LPL. Plasma TG and TC levels in adult LPLO/ApoEO mice were increased 76 and 14 fold, respectively, compared with wild-type littermates. Conclusion hypercholesterolemic/hypertriglyceridemic mouse model has been developed successfully.
出处 《中国比较医学杂志》 CAS 2005年第6期368-371,共4页 Chinese Journal of Comparative Medicine
基金 自然科学基金(30270539)
关键词 脂蛋白脂酶 载脂蛋白E类 双基因敲除小鼠 繁殖 Lipoprotein lipase Apolipoproteins E Double knockout mice Breeding
  • 相关文献

参考文献14

  • 1Zhang SH,Reddick RL,Piedrahita JA,et al.Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E[J].Science,1992,258:468-471.
  • 2Jan L,Breslow.Mouse models of atherosclerosis [ J ].Science,1996,272:685-689.
  • 3Piedrahita JA,Zhang SH,Hagaman JR,et al.Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proc Natl Acad Sci USA,1992,89:4471-4475.
  • 4Ishibashi S,Herz J,Maeda N,et al.The two-receptor model of lipoprotein clearance:Tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor,apolipoprotein E,or both proteins[ J].Proc Natl Acad Sci USA,1994,91:4431-4435.
  • 5钱学贤.现代心血管学(第1版)[M].北京:人民军医出版社,1999.457.
  • 6刘卫国,李作汉.载脂蛋白E与脑血管病[J].临床神经病学杂志,1999,12(5):315-316. 被引量:5
  • 7Chan LY,Lam CW,Mak YT,et al.Genotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia genetic basis of hypertriglyceridemia[ J ].Hum Mutat,2002,20:232-233.
  • 8Shen J,Chen R,Hu W,et al.A gene analysis of familial lipoprotein lipase deficiency in China[J].Chin J Med Genet,1999,16:233-235.
  • 9Hide WA,Chan L,Li WH.Structure and evolution of the lipase superfamily[J].J Lipid Res,1992,3:167-178.
  • 10杨涛,林青云,曾文和,陈婉姗,潘妙鹃,黄尚志,彭智培.中国人2型糖尿病合并高甘油三酯血症患者脂蛋白酯酶基因突变及功能分析[J].中国医学科学院学报,2003,25(2):134-141. 被引量:10

二级参考文献56

  • 1陆振华.人血浆载脂蛋白E(apoE):化学、遗传学及其测定的临床意义[J].陕西医学检验,1995,10(1):51-53. 被引量:1
  • 2HAHN P F. Abolishment of alimentary lipemia following injection of heparin[J]. Science, 1943,98:19.
  • 3KORN E D. Clearing factor, heparin-activated lipoprotein lipase[J]. J Biol Chem, 1955,215:1.
  • 4HAVEL R J, KANE J P, KASHYAP M L. Interchange of apolipoproteins between chylomicron and high density lipoproteins during alimentary lipemia in man[J].J Clin Invest, 1973,52:32.
  • 5GOTODA T, SENDA M, MURASE T, et al. Genetic polymorphism identified by Pvu Ⅱ RFLP in familial lipoprotein lipase deficiency[J]. Biochem Biophys Res Commun, 1989,164:1391.
  • 6GOTODA T, YAMADA N, KAWAMURA M, et al. Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency [ J ]. J Clin Invest, 1991,88:1856.
  • 7AUSTIN M A. Plasma triglyceride and coronary heart disease[J].Arterioscler Thrombo, 1991,11:2.
  • 8LAPIDUS L C, BENGTKSON O, LINDQIST J A, et al. Triglyceride:main lipid risk factor for cardiovascular disease in woman?[J]. Acta Med Scand, 1985,217:481.
  • 9CASTELLI W P. The triglyceride issue: a view from Framingham[J]. Am Heart J, 1986,112:432.
  • 10FONTBONE A E,ESCHWEGE F,CAMBIEN J L,et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of Paris Prospective Study[ J ]. Diabetologia,1989,32:300.

共引文献19

同被引文献44

  • 1王海勇,王林.降血脂药物的研究进展[J].国外医学(药学分册),2004,31(3):160-166. 被引量:36
  • 2杨小毅,杨永宗,谭健苗,袁中华,万载阳.一种纯系小鼠动脉粥样硬化病理模型的建立[J].中国动脉硬化杂志,1996,4(1):54-57. 被引量:27
  • 3王曦,李红霞,王靖宇.鼠数量性状QTL定位的研究进展[J].中国比较医学杂志,2006,16(4):249-254. 被引量:1
  • 4王亚楠,冼勋德,张晓红,刘国庆.遗传性混合型高脂血症小鼠的自发性动脉粥样硬化[J].中国动脉硬化杂志,2006,14(9):775-777. 被引量:7
  • 5Lichtenstein AH, Jalbert SM, Adlercreutz H, et al. Rasmussen Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholester- olemic subjects [J]. Arterioscler Thromb Vasc Biol, 2002, 22: 1852-1858.
  • 6Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial [J]. JAMA, 2004, 292:65-74.
  • 7Weggemans RM, Trautwein EA. Relation between soy-asso- ciated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis [J]. Eur J Clin Nutr, 2003, 57:940-946.
  • 8Squadrito F, Altavilla D, Morabito N, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium depen-dent vasodilation in postmenopausal women [J]. Atherosclerosis, 2002, 163:339-347.
  • 9Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies [J]. Am J Clin Nutr, 2003, 78:593S-609S.
  • 10Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer [J]. Br J Nutr, 2004, 91: 513-531.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部